Risk-Based Approach “Critical” To Securing Global Supply Chain – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA wants risk-based draft guidances it published this year to increase industry accountability and free resources for high-risk inspections as the number of foreign-sourced drugs entering the U.S. exceeds the agency's inspection capabilities
You may also be interested in...
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
Top-Down Responsibility Recommended For Import Safety Compliance
Responsibility for ensuring import safety starts at the top of the corporate ladder, FDA says in a draft guidance